| Study on GS300 on NAFLD (NCT04887766) | Gelesis, Inc. | 2022-07-01 |
| Metabolic Pathology of Pediatric NAFLD (NCT05430178) | University of Oklahoma | 2022-05-25 |
| Nonalcoholic Fatty Liver Disease - Intermittent Calorie Restriction (FLICR) Study (NCT05309642) | Ewha Womans University Mokdong Hospital | 2022-03-07 |
| Non-invasive Biomarkers of Metabolic Liver Disease (NIMBLE) Study 1.2 (NCT05081427) | Mayo Clinic | 2021-11-15 |
| Efficacy and Safety of Guanabenz for Nonalcoholic Fatty Liver Disease (NCT05084404) | Yokohama City University | 2021-10-29 |
| Noninvasive Biomarkers of Metabolic Liver Disease 1.1 (NCT04828551) | Massachusetts General Hospital | 2021-03-18 |
| Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes (NCT04595474) | Joslin Diabetes Center | 2021-01-14 |
| Efficacy and Safety of Elobixibat in Combination With Cholestyramine for Nonalcoholic Fatty Liver Disease (NCT04235205) | Yokohama City University | 2020-01-29 |
| Aspirin for the Treatment of Nonalcoholic Fatty Liver Disease (NCT04031729) | Massachusetts General Hospital | 2019-09-12 |
| A Study to Assess the Pharmacokinetics of PXL770 After 4 Weeks of Treatment in Subjects With NAFLD (NCT03950882) | Poxel SA | 2019-08-01 |
| Comparative and Additive Diagnostic Performance of Magnetic Resonance Elastography (MRE) and Corrected-T1 (cT1) for Fibrosis and Inflammation in Nonalcoholic Steatohepatitis (NASH) Using Histology As Reference (NCT04389593) | University of California, San Diego | 2019-05-21 |
| Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease (NCT03696797) | Wake Forest University Health Sciences | 2019-05-03 |
| A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD (NCT03763877) | Poxel SA | 2019-03-29 |
| Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance (NCT05165706) | Stanford University | 2019-01-31 |
| Great China Fatter Liver Consortium (GC_FLC) Study to Assess the Progress of NAFLD/NASH in Chinese (NCT03282305) | Great China Fatty Liver Consortium Limited | 2018-04-01 |
| Feasibility of VIIT in Adults With NASH (NCT03861819) | Duke University | 2018-01-01 |
| The Liver Health Study for Patients with NAFLD (NCT03151798) | University of Missouri-Columbia | 2017-08-09 |
| Curcumin Supplement in Nonalcoholic Fatty Liver Patients (NCT02908152) | National Nutrition and Food Technology Institute | 2017-02-10 |
| Molecules Associated With the Presence and Severity of Nonalcoholic Fatty Liver Disease (NCT03986684) | Hippocration General Hospital | 2017-01-05 |
| Crassostrea Gigas for Liver Health (NCT02992470) | Korean Medicine Hospital of Pusan National University | 2016-12-01 |
| Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD (NCT03725631) | Korea University Guro Hospital | 2016-09-01 |
| A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD) (NCT02815891) | Target PharmaSolutions, Inc. | 2016-07-01 |
| Fatty Liver Study in Patients With Type II Diabetes (NCT02365233) | The University of Texas Medical Branch, Galveston | 2013-05-01 |
| Vitamin D Replacement in Nonalcoholic Fatty Liver Disease (NCT03084328) | The Cleveland Clinic | 2012-01-20 |